Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Toronto

$22,000.00

Development of field deployable technologies for improved health and environmental outcomes

FY 2015-16

Summary
Diagnostic testing will continue to play a key role in the eradication of obesity and is central to determining the effectiveness of treatment strategies. The proposed device will perform an immunoassay capable of detecting biomarkers for obesity, e.g., CRP, IL-6 fibrinogen and TNF-alpha. It will use a novel droplet based microfluidic system and the immunochemistry will take place on the surface of microspheres held in solution. Surface tension forces will be used to manipulate nanolitre sized droplets by applying asymmetric electric fields. This technique can successfully control biological fluids such as whole blood and urine and eliminate complex components like channels or pumps. This straightforward geometry reduces fabrication costs and makes it easier to incorporate multiple reagents. By having the immunochemistry occur on particles in solution, the device can be easily adapted to detect biomarkers for various diseases by changing the reagents. This will ensure excellent selectivity and sensitivity with fast feedback. The long term goal of this proposal is to fully quantify protein suspension behaviour in electrosprays and digital microfluidic devices towards the goal of a portable, point-of-care diagnostic test for obesity treatment monitoring using a miniaturized, microfluidic-based DMF on dielectric device coupled with high-resolution IMS.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2015-05329
Name nom
Sullivan, Pierre
Department département
Mechanical and Industrial Engineering - Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
22000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2200
Research subject group en
Fluid mechanics
Research subject group fr
Mécanique des fluides
Research subject en
Fluid mechanics
Research subject fr
Mécanique des fluides
Partie
1
Nb partie
1
Application title
Development of field deployable technologies for improved health and environmental outcomes
Keyword
NSERC
Application summary
Diagnostic testing will continue to play a key role in the eradication of obesity and is central to determining the effectiveness of treatment strategies. The proposed device will perform an immunoassay capable of detecting biomarkers for obesity, e.g., CRP, IL-6 fibrinogen and TNF-alpha. It will use a novel droplet based microfluidic system and the immunochemistry will take place on the surface of microspheres held in solution. Surface tension forces will be used to manipulate nanolitre sized droplets by applying asymmetric electric fields. This technique can successfully control biological fluids such as whole blood and urine and eliminate complex components like channels or pumps. This straightforward geometry reduces fabrication costs and makes it easier to incorporate multiple reagents. By having the immunochemistry occur on particles in solution, the device can be easily adapted to detect biomarkers for various diseases by changing the reagents. This will ensure excellent selectivity and sensitivity with fast feedback. The long term goal of this proposal is to fully quantify protein suspension behaviour in electrosprays and digital microfluidic devices towards the goal of a portable, point-of-care diagnostic test for obesity treatment monitoring using a miniaturized, microfluidic-based DMF on dielectric device coupled with high-resolution IMS.